From: Anti-CNTN1 IgG3 induces acute conduction block and motor deficits in a passive transfer rat model
Rats injected with IgG of | Acute patient (n = 12) | Low titre patient (n = 15) | Chronic patient (n = 20) | Control animals (n = 36) | |
---|---|---|---|---|---|
Titre of IgG subclasses (predominant subclass in bold type) | IgG1 | 1:1000 | 1:100 | 1:500 | Negative |
IgG2 | negative | 1:100 | 1:1000 | ||
IgG3 | 1:7500 | 1:1000 | 1:5000 | ||
IgG4 | 1:500 | 1:1000 | 1:15,000 | ||
Binding subclass | In vitro | IgG3, (IgG4) | IgG4 | IgG4 | None |
In vivo | IgG3 | No binding detectable | IgG4 | ||
Conduction block | 83.3%* | 0% | 35% | 13.2% | |
Loss of F waves | 66.7%* | 0% | 40%* | 0% | |
Median CMAP ratio (distal/proximal) pre-/post-injection (mV) | 1.14 (1.03–1.34) | 1.18 (1.04–1.24) | 1.11 (0.89–1.38) | 1.12 (0.88–2.49) | |
3.32 (1.04–20.25)* | 1.18 (0.92–1.71) | 1.35 (1.07–13.35) | 1.23 (1.08–5.12) | ||
Median SNAP pre-/post-injection (μV) | 20.0 (6.9–29.9) | 17.4 (10.0–59.9) | 18.0 (0–26.1) | 17.8 (2.9–106) | |
8.8 (0–18.7)* | 13.2 (0.3–63.0) | 13.7 (1.3–30.9) | 15.7 (3.6–39.2) | ||
Median fall latency (s) | 205 (111–336) | 230 (64–396) | 231 (100–500) | 223 (71–401) | |
155 (54–222)* | 186 (76–297) | 185 (84–389) | 180 (67–343) | ||
Median standing time right hind paw (s) | 0.23 (0.17–0.28) | 0.24 (0.19–0.37) | 0.22 (0.17–0.52) | 0.24 (0.15–0.46) | |
0.18 (0.08–0.25)* | 0.24 (0.18–0.45) | 0.22 (0.11–0.44) | 0.24 (0.15–0.43) | ||
Median print area right hind paw (cm2) | 1.39 (0.54–2.18) | 1.89 (1.04–2.74) | 1.18 (0.45–1.73) | 1.30 (0.64–2.35) | |
0.88 (0.09–2.21)* | 2.07 (1.30–2.98) | 1.04 (0.32–1.51) | 1.61 (0.74–2.91) | ||
Median maximum intensity right hind paw (AU) | 217 (182–229) | 222 (207–232) | 212 (180–219) | 210 (173–232) | |
177 (83–234)* | 220 (206–234) | 202 (94–221) | 215 (165–235) |